Bened Life Partner Program

Bened Life partners with health care providers, community leaders, and other experts who are looking for new tools to support gut-brain health in the people they serve.

Start a conversation with us about how to talk to your community about Neuralli, the first neurologically active medical probiotic:

Recommend the only
medical probiotic for
neurological conditions

NeuralliTM is a neurologically active probiotic that works within the gut to enhance mood, mind and movement via the gut-brain axis.

It is specifically formulated as a medical food to assist in the dietary management of neurological conditions such as ASD, PD and ADHD.

What the clinical science says about NeuralliTM

Neuralli is powered by 60 billion CFUs of L. plantarum PS128, a neurologically active probiotic strain.

In three clinical studies of PS128 conducted with autistic people, neurological health benefits were seen in a significant number of participants1-3.

In a pilot study with 25 Parkinson’s disease patients taking PS128 alongside their own prescribed anti-Parkinsonian medications, participants noted significant improvements in motor symptoms and quality of life4.

What is Neuralli?

Neuralli is a medical probiotic containing the unique psychobiotic strain L. plantarum PS128 at the same dose utilized in 12 published clinical studies of neurological and mental health conditions.

PS128 is a psychobiotic - “a live organism that when ingested in adequate amounts produces a health benefit in patients suffering from a neurological illness.”

Neuralli is a medical food. The term medical food, as defined in section 5(b) of the Orphan Drug Act (21 U.S.C. 360ee (b) (3)) is "a food which is formulated to be consumed or administered enterally under the supervision of a physician and which is intended for the specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.

How it works

Research suggests that PS128, the active ingredient in Neuralli, has both probiotic and psychobiotic effects.

A psychobiotic is “a live organism that when ingested in adequate amounts produces a health benefit in patients suffering from a neurological illness.”

PS128’s psychobiotic effects are mediated by the gut-brain axis (GBA), allowing it to influence the central nervous system without leaving the intestinal lumen.

Neuralli facts at your fingertips

For Health Care Professionals

For Community Leaders

Let’s work together!

Learn to talk to your community about Neuralli.
Share your expertise with our company or our audience.
Become an affiliate.

No matter how you envision partnering with Bened Life, let’s start a conversation:

  1. Tell us about yourself with a quick 2 minute survey
  2. We’ll reach out via email
  3. If we’re a good fit for one another, we’ll set up a win-win partnership

Read the L. plantarum PS128 Clinical Studies for ASD

Each Neuralli dose contains the same amount of PS128 used in these studies.

Effects of L. plantarum PS128 on children with autism spectrum disorder in Taiwan: A randomized, double-blinded, placebo-controlled trial (2019)

Probiotic and oxytocin combination therapy in patients with autism spectrum disorder: A randomized, double-blinded, placebo-controlled pilot trial (2021)

L. plantarum PS128 and other probiotics in children and adolescents with autism spectrum disorder: A real-world experience (2021)

Our clinical portfolio doesn’t stop there

PS128 has been studied in other neurological conditions, and additional research is ongoing.

Our science team

At Bened Life, we stand on the shoulders of the microbiome experts at Bened Biomedical, our research-focused parent organization.

Bened Biomedical's R&D team of 6 PhD scientists is led by Professor Ying Chieh Tsai, whose distinguished 30+ year career in microbiology includes serving as the Director of Biochemistry at National Yang-Ming University (NYMU) School of Medicine in Taiwan.

Besides discovering L. plantarum PS128 and other psychobiotic strains, Bened’s scientists have collectively published more than 50 papers concerning the gut microbiome.